Raymond James Financial’s MiMedx Group MDXG Stock Holding History

Raymond James Financial’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40.2K	Sell	10,432 -573	-5%	-$2.09K	﹤0.01%	5282
2026 Q1	$43.5K	Sell	11,005 -76,547	-87%	-$386K	﹤0.01%	5134
2025 Q4	$593K	Sell	87,552 -71,295	-45%	-$500K	﹤0.01%	4144
2025 Q3	$1.11M	Buy	158,847 +6,461	+4%	+$44.9K	﹤0.01%	3615
2025 Q2	$931K	Buy	152,386 +64,878	+74%	+$431K	﹤0.01%	3634
2025 Q1	$665K	Sell	87,508 -4,699	-5%	-$39.3K	﹤0.01%	3753
2024 Q4	$887K	Buy	+92,207	New	+$718K	﹤0.01%	3533

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Raymond James Financial's MDXG Position: Q2 2026 in Review

Raymond James Financial reduced its MiMedx Group (MDXG) stake by 5.2% in Q2 2026, selling an estimated $2.09K and leaving 10,432 shares worth $40.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5282.

Raymond James Financial first reported a position in MDXG in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.11M in Q3 2025. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

Raymond James Financial held 10,432 shares of MiMedx Group worth $40.2K as of Q2 2026.
Raymond James Financial sold 573 MiMedx Group shares in Q2 2026, an estimated $2.09K.
MiMedx Group made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #5282 holding.
Raymond James Financial first reported a position in MiMedx Group in Q4 2024 and has held it in 7 quarters since.
Raymond James Financial's MiMedx Group position peaked at $1.11M in Q3 2025.
227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.